CVS Health (CVS)
(Delayed Data from NYSE)
$56.94 USD
+0.47 (0.83%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$56.94 USD
+0.47 (0.83%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $91.98, moving -1% from the previous trading session.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $93.45, moving +0.74% from the previous trading session.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $93.02 in the latest trading session, marking a -0.58% move from the prior day.
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $95, marking a -0.05% move from the previous day.
CVS Health (CVS) Stock Moves -0.42%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $95.05, moving -0.42% from the previous trading session.
The Zacks Analyst Blog Highlights Verizon Communications, Honeywell International, CVS Health, Intuit and Incyte
by Zacks Equity Research
Verizon Communications, Honeywell International, CVS Health, Intuit and Incyte are included in this Analyst Blog.
Top Research Reports for Verizon, Honeywell & CVS Health
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks,including Verizon Communications Inc. (VZ), Honeywell International Inc. (HON) and CVS Health Corporation (CVS).
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Foot Locker (FL) Stock Up 8.7% on Q3 Earnings and Sales Beat
by Zacks Equity Research
Foot Locker (FL) posts better-than-expected earnings for third-quarter fiscal 2022. FL's FLX membership program and omnichannel capabilities appear encouraging.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Company News for Nov 3, 2022
by Zacks Equity Research
Companies In The News Are: CVS, HUM, ETR, NVO.
CVS Health (CVS) Q3 Earnings Surpass Estimates, View Up
by Zacks Equity Research
Robust sales growth across all three operating segments drive CVS Health's (CVS) top line.
CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 5.03% and 6.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 22.97% and 0.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Should Investors Buy CVS Stock Before Q3 Earnings?
by Shaun Pruitt
Trading 15% from its highs, CVS (CVS) is set to report Q3 earnings on Wednesday, November 2. Investors hope the company can capitalize on its ambition to sustain itself as an industry leader as the Retail-Pharmacies Drug Stores Industry is currently in the top 18% of over 250 Zacks Industries.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $92.73, marking a +0.55% move from the previous day.
CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CVS Health's (CVS) digital capabilities are anticipated to have enhanced consumer engagement across all CVS Health businesses in Q3.
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon's
by Zacks Equity Research
CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon's are part of Zacks Industry Outlook article.
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain from the growing demand for digital healthcare support. However, reimbursement challenges are hurting overall industry health.
CVS Health (CVS) Stock Moves -0.73%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $90.99, marking a -0.73% move from the previous day.
CVS Health (CVS) Stock Moves -0.89%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $89.30 in the latest trading session, marking a -0.89% move from the prior day.
The Zacks Analyst Blog Highlights Chevron, Amgen, HSBC, CVS Health and S&P Global
by Zacks Equity Research
Chevron, Amgen, HSBC, CVS Health and S&P Global are included in this Analyst Blog.